Back to
FIRST MANHATTAN CO. LLC.
KNSA
Showing 0 of 4 quarters
Position history for
FIRST MANHATTAN CO. LLC.'s holdings in KINIKSA PHARMACEUTICALS-A
No. First Manhattan exited its KNSA (Kiniksa Pharmaceuticals) position in Q3 2019. Its Q2 2019 13F listed 63,976 shares worth $866,000. First Manhattan already held KNSA in its Q4 2018 13F, the earliest on record, and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.